BRPI0811290A2 - Eliminação de interferência em imunoensaios causada por anticorpos anticarboidrato - Google Patents

Eliminação de interferência em imunoensaios causada por anticorpos anticarboidrato

Info

Publication number
BRPI0811290A2
BRPI0811290A2 BRPI0811290-8A2A BRPI0811290A BRPI0811290A2 BR PI0811290 A2 BRPI0811290 A2 BR PI0811290A2 BR PI0811290 A BRPI0811290 A BR PI0811290A BR PI0811290 A2 BRPI0811290 A2 BR PI0811290A2
Authority
BR
Brazil
Prior art keywords
antibodies
carbide
elimination
interference caused
immunoassay interference
Prior art date
Application number
BRPI0811290-8A2A
Other languages
English (en)
Inventor
David Leroy Wensel
Michael Awwad
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0811290A2 publication Critical patent/BRPI0811290A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0811290-8A2A 2007-05-07 2008-05-06 Eliminação de interferência em imunoensaios causada por anticorpos anticarboidrato BRPI0811290A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92814407P 2007-05-07 2007-05-07
US92843807P 2007-05-08 2007-05-08
PCT/US2008/062739 WO2008137885A1 (en) 2007-05-07 2008-05-06 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Publications (1)

Publication Number Publication Date
BRPI0811290A2 true BRPI0811290A2 (pt) 2014-10-21

Family

ID=39666131

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811290-8A2A BRPI0811290A2 (pt) 2007-05-07 2008-05-06 Eliminação de interferência em imunoensaios causada por anticorpos anticarboidrato

Country Status (11)

Country Link
EP (1) EP2142925A1 (pt)
JP (1) JP2010527005A (pt)
KR (1) KR20100029083A (pt)
CN (1) CN101680880A (pt)
AU (1) AU2008247352A1 (pt)
BR (1) BRPI0811290A2 (pt)
CA (1) CA2686206A1 (pt)
IL (1) IL201907A0 (pt)
MX (2) MX2009012048A (pt)
RU (1) RU2009141159A (pt)
WO (1) WO2008137885A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS54249B1 (en) 2010-04-29 2016-02-29 Theradiag Sa PROCEDURE FOR DETECTION OF ANTI-MEDICINAL ANTIBODIES
MX2016010413A (es) 2014-02-11 2016-11-30 Genzyme Corp Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
EP3176580A1 (en) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
GB201522839D0 (en) * 2015-12-23 2016-02-03 Randox Lab Ltd And Randox Teoranta Method
BR112018076569A2 (pt) * 2016-06-23 2019-04-02 Ablynx Nv ensaios farmacocinéticos melhorados para domínios variáveis simples de imunoglobulina
CN108535490A (zh) * 2017-03-06 2018-09-14 苏州和锐生物科技有限公司 生物制剂血药浓度检测方法及试剂
EP3821255A1 (en) * 2018-07-10 2021-05-19 Regeneron Pharmaceuticals, Inc. Methods for mitigating drug target interference in an anti-drug antibody (ada) immunoassay
CN113514632B (zh) * 2021-04-20 2024-06-25 中国科学技术大学 基于纳米抗体的微悬臂梁免疫传感方法
WO2023204378A1 (ko) * 2022-04-19 2023-10-26 의료법인 성광의료재단 혈액 내 항-약물항체 농도 측정을 통한 생물학적 약물에 대한 치료 반응성 예측 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705353A (en) * 1995-06-07 1998-01-06 Beckman Instruments, Inc. Method of reducing interferences in assays
US5856106A (en) * 1995-11-01 1999-01-05 Biotransplant, Inc. Determination of antibody production against administered therapeutic glycoproteins, especially monoclonal antibodies

Also Published As

Publication number Publication date
IL201907A0 (en) 2010-06-16
RU2009141159A (ru) 2011-06-20
KR20100029083A (ko) 2010-03-15
AU2008247352A1 (en) 2008-11-13
WO2008137885A1 (en) 2008-11-13
MX2009012048A (es) 2010-02-24
CN101680880A (zh) 2010-03-24
JP2010527005A (ja) 2010-08-05
MX2009012044A (es) 2009-11-18
CA2686206A1 (en) 2008-11-13
EP2142925A1 (en) 2010-01-13

Similar Documents

Publication Publication Date Title
CY2019004I2 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
SMT201700083B (it) Anticorpi monoclonali
NO344963B1 (no) Humanisert antistoff
BRPI0811290A2 (pt) Eliminação de interferência em imunoensaios causada por anticorpos anticarboidrato
CR10823A (es) Formulacion parenteral de anticuerpos abeta
DK2131860T3 (da) Anti-sclerostin-antistoffer
BRPI0907237A2 (pt) Anticorpo anti-cldn6
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
BRPI0923359A2 (pt) Anticorpos anti-igf
BRPI0817273A2 (pt) Região constante de anticorpo modificada
BRPI0922800A2 (pt) anticorpos c-met
BRPI0920961A2 (pt) mecanismo de procura estrutura de emprego
DK2066695T3 (da) Anti-myostatin-antistoffer
BRPI0915491A2 (pt) sensor de imunoensaio
BRPI0820819A2 (pt) Formulação de anticorpos
DE602008003347D1 (de) Tonerverfahren
BRPI0916915A2 (pt) anticorpos anti-il-17a/f de reatividade cruzada e biespecíficos
BRPI0922730A2 (pt) formulação de anticorpo
BRPI0917833A2 (pt) compensação de movimento antecipado de dispositivo
BRPI0819210A2 (pt) Anticorpos de proteína g anti-rsv
SG10201601279SA (en) Monoclonal Antibody STRO-4
FI20075278A0 (fi) Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
BR112012003602A2 (pt) imunoensaio de imatinibe
CR10705A (es) Anticuerpos para linfotoxina-alfa

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]